E3710 + E3710
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Gastroesophageal Reflux Disease
Conditions
Gastroesophageal Reflux Disease
Trial Timeline
Jul 1, 2011 → Oct 1, 2011
NCT ID
NCT01390714About E3710 + E3710
E3710 + E3710 is a phase 1 stage product being developed by Eisai for Gastroesophageal Reflux Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01390714. Target conditions include Gastroesophageal Reflux Disease.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01390714 | Phase 1 | Completed |
Competing Products
20 competing products in Gastroesophageal Reflux Disease